Discussion on the Key Points of Article Describing Adverse Drug Reaction Case in Pharmaceutical Journal

Abstract

Abstract: Objective To provide the reference for writing, auditing and editing of pharmaceutical journal articles about adverse drug reaction (ADR) case reports.Methods By collecting the correlative papers in science and technology core journals of pharmacy category, combining the key points of evaluation of ADR case reports, the key points of writing, auditing and editing of the case report were analyzed.Results & ConclusionThe reference value of serious, unlisted and rare ADRs is higher. The contents of article should be around nature judgement of ADR case and causality analysis. Through describing a case and analyzing literature, the articles should summarize or speculate the characteristics and the possible mechanisms, put forward problems that should be paid attention in clinical medication and measures to prevent and deal with similar ADRs.

Key words: adverse drug reaction(ADR), case report, article, key point

CLC Number:

R994.11

FAN Yan, TANG Ren, JING Chun-mei ,LI Xin-ling. Discussion on the Key Points of Article Describing Adverse Drug Reaction Case in Pharmaceutical Journal[J]. Chinese Journal of Pharmacovigilance, 2017, 14(2): 99-101.

References

[1] 游苏宁,石朝云. 应重视科技学术期刊的社会责任[J]. 编辑学报,2008, 20（6）：471.
[2] 任胜利. 我国科技期刊现状及其在学术交流中的作用[J]. 中国科技期刊研究,2007, 18（3）：357-359.
[3] 范燕. 刍议药学期刊论文的编写格式[J]. 编辑之友,2011,7：80.
[4] 王艳. 《新疆医科大学学报》开设特色栏目的实践体会[J]. 中国科技期刊研究,2014, 25（3）：450.
[5] 李鹏,丁惠国．常用临床科研设计方法及应用[J]．北京医学,2013,35(3) :233.
[6] 王耀．临床科研设计的要点[J]．华人消化杂志,1998,6(10):917.
[7] CFDA.国家药品不良反应监测年度报告（2015年）[EB/OL].(2016-07-13)[2017-01-01]. http://www.sda.gov.cn/WS01/CL0053/62621.html.
[8] 卫生部.药品不良反应报告和监测管理办法（卫生部令第81号）[S/OL]. (2011-05-04)[2017-01-01]. http://www.sda.gov.cn/WS01/CL0053/62621.html.
[9] UMC. The use of the WHO-UMC system for standardised case causality assessment [EB/OL]. [2017-01-01].https://www.who-umc.org/media/2768/standardised-case-causality-assessment.pdf.
[10] 王致兵. 学报论文题目的编写思考[J]. 教师, 2010, 2：126.
[11] 郑海蓉. 医学论文题名中存在的问题及实例分析与修改[J]. 编辑学报, 2015, 27(2)：143.
[12] 孙群,黄杰藩．精选标题妙传信息-科技论文标题40例分析[J]. 情报学报, 1995, 14(4):308．
[13] 国家药典委员会. 中国药品通用名称命名原则[M/OL]. (2006-09-21)[2016-01-02]. http://www.chp.org.cn/view/402887ab4d2732e7014d273347bc0020?a=XWJX.
[14] Impicciatore P, Mucci M. Completeness of published case reports on suspected adverse drug reactions: evaluation of 100 reports from a company safety database[J]. Drug Safety, 2010, 33(9):765-773.
[15] Kanamoto M, Shimada M, Ikegami T, et al. Real time elastography for noninvasive diagnosis of liver fibrosis[J]. 2009, 16(4):463-467.
[16] 王秋红,许卓文. 医学论文中讨论的写作[J]. 临床荟萃,2013,28(11)：1254.
[17] 中国药物警戒. 中国药物警戒投稿指南[EB/OL]. [2009-01-01] [2016-01-02]. http://manu36.magtech.com.cn/zgywjj/CN/column/column24.shtml.
[18] 赵珊珊,李静,李瑞花. 阿司匹林致非糖尿病患者严重低血糖死亡1例[J]. 中国药物警戒, 2015, 12, (12)：766.
[19] 王小寒,冷怀明. 编辑初审临床医学论文发现的科研设计常见问题及处理策略[J]. 编辑学报, 2015, 27(1)：38.